# A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

Study · id `cardio:ct-nct06785116` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06785116](<https://clinicaltrials.gov/study/NCT06785116>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06785116

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06785116. Randomized; quadruple masking; primary purpose treatment. Start 2025-03-02 (actual); primary completion 2028-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06785116, source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)
- Started: 2025-03-02 (actual) (ClinicalTrials.gov record NCT06785116, source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)
- Primary completion: 2028-08 (anticipated) (ClinicalTrials.gov record NCT06785116, source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)
- Completion: 2028-08 (anticipated) (ClinicalTrials.gov record NCT06785116, source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06785116, source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06785116-2026-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)
- Acronym: DAPA-HP
- Condition: Gestational Hypertension
- Condition: Hypertension in Pregnancy
- Condition: Pre-Eclampsia
- Condition: Superimposed Pre-Eclampsia
- Condition: Cardiovascular Complication
- Intervention (Drug): Placebo
- Intervention (Drug): Dapagliflozin 10mg Tab
- Lead sponsor: University of Michigan
- Lead sponsor class: OTHER
- Collaborator: Society for Maternal-Fetal Medicine Foundation
- Collaborator class: UNKNOWN
- Collaborator: American Association of Obstetricians and Gynecologists Foundation
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Dapagliflozin (`cardio:dapagliflozin`)
- Registry intervention is a member of this class by a sourced record link: SGLT2 inhibitors (drug class) (`cardio:sglt2-inhibitors`)
- Registry lists this organization as the lead sponsor: University of Michigan (`cardio:org-university-of-michigan`)

## Provenance

Content hash: f7ea1fc32310902174453f7344a9d8f2bebf9b83a2ccd014376d85e096fd08ff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
